Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter to Shareholders from Patriot Scientific President and CEO Rick Goerner

To me at least, it does mention it...when he says...

which fully reflects the financial results of all transactions announced prior to the end of January 2008".

Looks like the J's were in there based on the way he worded that sentence, but as usual iwe can't be sure.

I understand the privacy issue on license fees and settlemenets..just tell us plainly, if all monetary funds including the J's are in this Q and are there any ongoing revenues from royalties  in future quarters,without saying how much or from whom.

Share
New Message
Please login to post a reply